Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Merck & Co., Inc.MRK · Entity 2807 | Exe VP&Chief Ethics & ComplOff | May 10, 2012 | May 10, 2012 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Merck & Co., Inc.
Report date May 10, 2012 · Filed May 10, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 73,540 |
Ending reported balance
After 2012-05-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2012-05-10 · Exercise / conversion · Acquired 27,377 · Balance 100,917 Row 2 · 2012-05-10 · Sale · Disposed 27,377 · Balance 73,540 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.66 · Expires 2015-04-30 | Direct | 0 |
Reported balance
After 2012-05-10 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2012-05-10 · Exercise / conversion · Disposed 27,377 · Balance 0 |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian | 252 |
Reported balance
Holding disclosure · report date 2012-05-10 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 252 |
| Common Stock - 401(k) PlanSEC Table I · non-derivative | IndirectBy 401(k) | 3,753.1015 |
Reported balance
Holding disclosure · report date 2012-05-10 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 3,753.1015 F1: Includes shares acquired and dividends earned through April 6, 2012 in the MSD Employee Savings and Security Plan, a 401(k) plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes shares acquired and dividends earned through April 6, 2012 in the MSD Employee Savings and Security Plan, a 401(k) plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 10, 2012 Filed May 10, 2012 19:05 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionStock Option (right to buy) · Derivative | 27,377 | $0.00 Strike: $20.66 | $0.00 |
DisclosureSEC source: 0001225208-12-011833 · doc4.xml · derivative · entry 5 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,377 shares Expires 2015-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2012 Filed May 10, 2012 19:05 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 27,377 | $38.50 | $1,054,014.50 |
DisclosureSEC source: 0001225208-12-011833 · doc4.xml · nonDerivative · entry 2 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,540 Read SEC document |
| May 10, 2012 Filed May 10, 2012 19:05 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 27,377 | $20.66 | $565,608.82 |
DisclosureSEC source: 0001225208-12-011833 · doc4.xml · nonDerivative · entry 1 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionStock Option (right to buy) · Derivative | 20,192 | $0.00 Strike: $21.08 | $0.00 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · derivative · entry 22 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,192 shares Expires 2013-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionStock Option (right to buy) · Derivative | 22,175 | $0.00 Strike: $38.01 | $0.00 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · derivative · entry 21 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,175 shares Expires 2012-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 15,800 | $38.77 | $612,566.00 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 18 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,540 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 7,030 | $38.78 | $272,623.40 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 17 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,340 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 6,677 | $38.79 | $259,000.83 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 16 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,370 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 4,700 | $38.76 | $182,172.00 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 15 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,047 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 4,700 | $38.81 | $182,407.00 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 14 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,747 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 1,100 | $38.80 | $42,680.00 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 13 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,447 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 755 | $38.79 | $29,288.34 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 12 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,547 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 300 | $38.78 | $11,634.75 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 11 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,302 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 234 | $38.82 | $9,082.71 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 10 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,602 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 210 | $38.81 | $8,150.63 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 9 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,836 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 200 | $38.79 | $7,757.98 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 8 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,046 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 200 | $38.80 | $7,759.00 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 7 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,246 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 173 | $38.79 | $6,710.69 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 6 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,446 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 100 | $38.77 | $3,876.50 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 5 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,619 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 100 | $38.77 | $3,877.25 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 4 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,719 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 88 | $38.82 | $3,416.16 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 3 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,819 Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 20,192 | $21.08 | $425,647.36 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 2 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 16:04 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 22,175 | $38.01 | $842,871.75 |
DisclosureSEC source: 0001225208-12-004753 · doc4.xml · nonDerivative · entry 1 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2011 Filed Jan 4, 2012 21:24 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 3,964 | $37.70 | $149,442.80 |
DisclosureSEC source: 0001225208-12-000517 · doc4.xml · nonDerivative · entry 1 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,540 F1 · shares: Withheld shares related to the 12/31/11 vesting of stock units previously granted to the reporting person on March 30, 2009. F2 · balance_after: Holdings include dividends earned since November 3, 2009. Read SEC document |
| November 11, 2011 Filed Nov 14, 2011 18:56 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $21.08 | $0.00 |
DisclosureSEC source: 0001225208-11-024711 · doc4.xml · derivative · entry 6 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,192 Underlying: Common Stock · 30,000 shares Expires 2013-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2011 Filed Nov 14, 2011 18:56 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 26,700 | $35.90 | $958,530.00 |
DisclosureSEC source: 0001225208-11-024711 · doc4.xml · nonDerivative · entry 3 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,575 Read SEC document |
| November 11, 2011 Filed Nov 14, 2011 18:56 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 3,300 | $35.90 | $118,470.33 |
DisclosureSEC source: 0001225208-11-024711 · doc4.xml · nonDerivative · entry 2 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,275 Read SEC document |
| November 11, 2011 Filed Nov 14, 2011 18:56 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 30,000 | $21.08 | $632,400.00 |
DisclosureSEC source: 0001225208-11-024711 · doc4.xml · nonDerivative · entry 1 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 44,776 | $0.00 Strike: $36.56 | $0.00 |
DisclosureSEC source: 0001225208-11-013359 · doc4.xml · derivative · entry 10 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,776 Underlying: Common Stock · 44,776 shares Expires 2021-05-03 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 4, 2012. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionStock Option (right to buy) · Derivative | 29,755 | $0.00 Strike: $22.69 | $0.00 |
DisclosureSEC source: 0001225208-11-013359 · doc4.xml · derivative · entry 9 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,755 shares Expires 2015-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 3,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-11-013359 · doc4.xml · derivative · entry 8 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,282 Underlying: Common Stock · 3,282 shares Expires 2014-05-04 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 14,107 | $36.55 | $515,610.85 |
DisclosureSEC source: 0001225208-11-013359 · doc4.xml · nonDerivative · entry 5 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,575 Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 13,300 | $36.56 | $486,248.00 |
DisclosureSEC source: 0001225208-11-013359 · doc4.xml · nonDerivative · entry 4 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,682 Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 2,248 | $36.57 | $82,209.36 |
DisclosureSEC source: 0001225208-11-013359 · doc4.xml · nonDerivative · entry 3 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,982 Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | SaleCommon Stock | 100 | $36.56 | $3,655.50 |
DisclosureSEC source: 0001225208-11-013359 · doc4.xml · nonDerivative · entry 2 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,230 Read SEC document |
| May 04, 2011 Filed May 6, 2011 14:42 UTC | Merck & Co., Inc. MRK · Entity 2807 | Exercise / conversionCommon Stock | 29,755 | $22.69 | $675,140.95 |
DisclosureSEC source: 0001225208-11-013359 · doc4.xml · nonDerivative · entry 1 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,330 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2010 Filed Jan 4, 2011 20:44 UTC | Merck & Co., Inc. MRK · Entity 2807 | Tax withholdingCommon Stock | 4,579 | $36.04 | $165,027.16 |
DisclosureSEC source: 0001225208-11-000549 · doc4.xml · nonDerivative · entry 1 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,575 F1 · shares: Withheld shares relate to the December 31, 2010, vesting of stock units previously granted to the reporting person on February 28, 2008. Read SEC document |
| May 07, 2010 Filed May 11, 2010 21:24 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantStock Option (right to buy) · Derivative | 28,812 | $0.00 Strike: $33.49 | $0.00 |
DisclosureSEC source: 0001225208-10-012652 · doc4.xml · derivative · entry 5 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,812 Underlying: Common Stock · 28,812 shares Expires 2020-05-06 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 7, 2011. Read SEC document |
| May 07, 2010 Filed May 11, 2010 21:24 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 3,583 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-012652 · doc4.xml · derivative · entry 4 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,583 Underlying: Common Stock · 3,583 shares Expires 2013-05-07 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| February 24, 2010 Filed Feb 24, 2010 23:03 UTC | Merck & Co., Inc. (MRK) · Entity 2807 | Exercise / conversionEmployee Stock Option 2005/04/25 (right to buy) · Derivative | 25,000 | $0.00 Strike: $22.69 | $0.00 |
DisclosureSEC source: 0001209191-10-011875 · doc4.xml · derivative · entry 8 Bowles Richard S III · CIK 0001475384 · Ex.VP&ChiefComp.Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,755 Underlying: Common Stock · 25,000 shares Expires 2015-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2010 Filed Feb 24, 2010 23:03 UTC | Merck & Co., Inc. (MRK) · Entity 2807 | Exercise / conversionEmployee Stock Option 2004/02/23 (right to buy) · Derivative | 54,755 | $0.00 Strike: $19.95 | $0.00 |
DisclosureSEC source: 0001209191-10-011875 · doc4.xml · derivative · entry 7 Bowles Richard S III · CIK 0001475384 · Ex.VP&ChiefComp.Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,755 shares Expires 2014-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2010 Filed Feb 24, 2010 23:03 UTC | Merck & Co., Inc. (MRK) · Entity 2807 | SaleCommon Stock | 25,000 | $37.00 | $925,000.00 |
DisclosureSEC source: 0001209191-10-011875 · doc4.xml · nonDerivative · entry 4 Bowles Richard S III · CIK 0001475384 · Ex.VP&ChiefComp.Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,573 Read SEC document |
| February 24, 2010 Filed Feb 24, 2010 23:03 UTC | Merck & Co., Inc. (MRK) · Entity 2807 | Exercise / conversionCommon Stock | 25,000 | $22.69 | $567,250.00 |
DisclosureSEC source: 0001209191-10-011875 · doc4.xml · nonDerivative · entry 3 Bowles Richard S III · CIK 0001475384 · Ex.VP&ChiefComp.Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,573 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2010 Filed Feb 24, 2010 23:03 UTC | Merck & Co., Inc. (MRK) · Entity 2807 | SaleCommon Stock | 54,755 | $37.00 | $2,025,935.00 |
DisclosureSEC source: 0001209191-10-011875 · doc4.xml · nonDerivative · entry 2 Bowles Richard S III · CIK 0001475384 · Ex.VP&ChiefComp.Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,573 Read SEC document |
| February 24, 2010 Filed Feb 24, 2010 23:03 UTC | Merck & Co., Inc. (MRK) · Entity 2807 | Exercise / conversionCommon Stock | 54,755 | $19.95 | $1,092,362.25 |
DisclosureSEC source: 0001209191-10-011875 · doc4.xml · nonDerivative · entry 1 Bowles Richard S III · CIK 0001475384 · Ex.VP&ChiefComp.Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,328 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2010 Filed Feb 22, 2010 22:23 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantRestricted Stock Unit · Derivative | 13,337 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-005224 · doc4.xml · derivative · entry 1 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,337 Underlying: Common Stock · 13,337 shares Expires 2013-02-19 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| November 19, 2009 Filed Nov 23, 2009 21:54 UTC | Merck & Co., Inc. MRK · Entity 2807 | GrantCommon Stock | 11,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-022752 · doc4.xml · nonDerivative · entry 1 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,859 F1 · shares: The acquisition of the shares was subject to the achievement of performance goals approved by the Compensation Committee of the Issuer. The shares will become payable on December 31, 2011 provided that the reporting person remains continuously employed by the Issuer through that date, or, if sooner, upon the reporting person's involuntary termination of employment other than for cause. Read SEC document |
| November 03, 2009 Filed Nov 7, 2009 00:03 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerStock Option (right to buy) · Derivative | 2,702 | $0.00 Strike: $22.91 | $0.00 |
DisclosureSEC source: 0001225208-09-021905 · doc4.xml · derivative · entry 13 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,098 Underlying: Common Stock · 2,702 shares Expires 2016-04-30 F14 · derivative.exercise_price: The option price for the grant expiring 4/30/16 will convert from $22.91 to 25.11. F6 · price: Pursuant to the Merger Agreement, upon the closing of the Transactions, the option was converted into an option to purchase common shares of New Merck in accordance with the exchange ratio set forth in the Merger Agreement, including an adjustment to the number of shares underlying the option and the option's exercise price. F5 · derivative.exercise_date: The option vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Certain options vested in connection with the closing of the Transactions. Following the Transactions, options continue pursuant to the same terms as were applicable prior to the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 7, 2009 00:03 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerStock Option (right to buy) · Derivative | 2,631 | $0.00 Strike: $18.85 | $0.00 |
DisclosureSEC source: 0001225208-09-021905 · doc4.xml · derivative · entry 12 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,369 Underlying: Common Stock · 2,631 shares Expires 2015-04-30 F13 · derivative.exercise_price: The option price for the grant expiring 4/30/15 will convert from $18.85 to $20.66. F6 · price: Pursuant to the Merger Agreement, upon the closing of the Transactions, the option was converted into an option to purchase common shares of New Merck in accordance with the exchange ratio set forth in the Merger Agreement, including an adjustment to the number of shares underlying the option and the option's exercise price. F5 · derivative.exercise_date: The option vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Certain options vested in connection with the closing of the Transactions. Following the Transactions, options continue pursuant to the same terms as were applicable prior to the Transactions. Read SEC document |
| November 03, 2009 Filed Nov 7, 2009 00:03 UTC | Merck & Co., Inc. MRK · Entity 2807 | Disposition to issuerStock Option (right to buy) · Derivative | 4,385 | $0.00 Strike: $31.57 | $0.00 |
DisclosureSEC source: 0001225208-09-021905 · doc4.xml · derivative · entry 11 Bowles Richard S III · CIK 0001475384 · Exe V-P & Chief Compl Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,615 Underlying: Common Stock · 4,385 shares Expires 2014-04-30 F12 · derivative.exercise_price: The option price for the grant expiring 4/30/14 will convert from $31.57 to $34.60. F6 · price: Pursuant to the Merger Agreement, upon the closing of the Transactions, the option was converted into an option to purchase common shares of New Merck in accordance with the exchange ratio set forth in the Merger Agreement, including an adjustment to the number of shares underlying the option and the option's exercise price. F5 · derivative.exercise_date: The option vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Certain options vested in connection with the closing of the Transactions. Following the Transactions, options continue pursuant to the same terms as were applicable prior to the Transactions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.